Article
Genetic basis for in vivo daptomycin resistance in enterococci.
The New England journal of medicine - 8 Sept 2011
Arias Cesar A, Panesso Diana, McGrath Danielle M, Qin Xiang, Mojica Maria F, Miller Corwin, Diaz Lorena, Tran Truc T, Rincon Sandra, Barbu E Magda, Reyes Jinnethe, Roh Jung H, Lobos Elizabeth, Sodergren Erica, Pasqualini Renata, Arap Wadih, Quinn John P, Shamoo Yousif, Murray Barbara E, Weinstock George M
Abstract excerpt
BACKGROUND: Daptomycin is a lipopeptide with bactericidal activity that acts on the cell membrane of enterococci and is often used off-label to treat patients infected with vancomycin-resistant enterococci. However, the emergence of resistance to daptomycin during therapy threatens its usefulness. METHODS: We performed whole-genome sequencing and characterization of the cell envelope of a clinical pair of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
